Patents by Inventor Maxim Vladimirovich Skulachev

Maxim Vladimirovich Skulachev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10188669
    Abstract: A method for providing to a mammal a neuroprotective effect against a brain pathology that is associated with reactive oxygen species originating from mitochondria (mROS). The method includes the step of administering to the mammal an SkQ mitochondria-targeted antioxidant in an amount effective to provide said neuroprotective effect. The SkQ mitochondria-targeted antioxidant may be administered either prophylactically or for treatment with respect to brain pathologies other than brain trauma or stroke, and may be administered for treatment of brain trauma or stroke.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: January 29, 2019
    Assignee: MITOTECH S.A.
    Inventors: Maxim Vladimirovich Skulachev, Vladimir Petrovich Skulachev, Maxim Viktorovich Egorov, Nikolai Konstantinovich Isaev, Nadezhda Anatolievna Kapay, Dmitry Borisovich Zorov, Elena Viktorovna Stelmashuk, Fedor Fedorovich Severin
  • Publication number: 20160361245
    Abstract: Dislosed are compositions comprising SkQ1 for protection of the skin from damage caused by free radicals and/or re active oxygen species.
    Type: Application
    Filed: February 25, 2015
    Publication date: December 15, 2016
    Applicant: MITOTECH SA
    Inventors: VALERIYA VLADIMIROVNA PELEKH, Valeriy Vasilieveech Lyandin, Anna Vladimirovna Shibaeva, Maxim Vladimirovich Skulachev, Lawrence T Friedhoff
  • Publication number: 20160354392
    Abstract: A method for providing to a mammal a neuroprotective effect against a brain pathology that is associated with reactive oxygen species originating from mitochondria (mROS). The method includes the step of administering to the mammal an SkQ mitochondria-targeted antioxidant in an amount effective to provide said neuroprotective effect. The SkQ mitochondria-targeted antioxidant may be administered either prophylactically or for treatment with respect to brain pathologies other than brain trauma or stroke, and may be administered for treatment of brain trauma or stroke.
    Type: Application
    Filed: March 2, 2016
    Publication date: December 8, 2016
    Applicant: MITOTECH S.A.
    Inventors: Maxim Vladimirovich SKULACHEV, Vladimir Petrovich SKULACHEV, Maxim Viktorovich EGOROV, Nikolai Konstantinovich ISAEV, Nadezhda Anatolievna KAPAY, Dmitry Borisovich ZOROV, Elena Viktorovna STELMASHUK, Fedor Fedorovich SEVERIN
  • Publication number: 20140329776
    Abstract: A method for providing to a mammal a neuroprotective effect against a brain pathology that is associated with reactive oxygen species originating from mitochondria (mROS). The method includes the step of administering to the mammal an SkQ mitochondria-targeted antioxidant in an amount effective to provide said neuroprotective effect. The SkQ mitochondria-targeted antioxidant may be administered either prophylactically or for treatment with respect to brain pathologies other than brain trauma or stroke, and may be administered for treatment of brain trauma or stroke.
    Type: Application
    Filed: September 21, 2012
    Publication date: November 6, 2014
    Applicant: MITOTECH S.A.
    Inventors: Maxim Vladimirovich Skulachev, Vladimir Petrovich Skulachev, Maxim Viktorovich Egorov, Fedor Fedorovich Severin, Dmitry Borisovich Zorov, Elena Viktorovna Stelmashuk, Nikolai Konstantinovich Isaev, Nadezhda Anatolievna Kapay
  • Patent number: 8557733
    Abstract: The present invention relates to biotechnology. The invention can be used for stimulation of regeneration of plants from tissues and undifferentiated cells cultivated under artificial conditions. The present invention can also be applied in agriculture for acceleration of germination of seeds, increase in germination of aged, long-stored seeds as well as for increase of resistance of plants to biotic and abiotic stresses.
    Type: Grant
    Filed: October 20, 2006
    Date of Patent: October 15, 2013
    Assignee: Mitotech S.A.
    Inventors: Vladimir Petrovich Skulachev, Maxim Vladimirovich Skulachev
  • Patent number: 8518915
    Abstract: The invention relates to pharmacology and medicine, in particular to a class of mitochondrially-addressed compounds which can be used in the pharmaceutical compositions of medicinal agents (preparations) for preventing and treating cardiovascular diseases and diseases and pathological conditions caused by disturbed blood circulation or oxygen supply to tissues and organs.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: August 27, 2013
    Assignee: Mitotech SA
    Inventors: Maxim Vladimirovich Skulachev, Vladimir Petrovich Skulachev
  • Publication number: 20130203843
    Abstract: The present invention relates to biology and medicine and in particular can be used in medicine for the preparation of a pharmaceutical composition for the specific, self-regulating uncoupling of mitochondria. The invention can be useful in the treatment of diseases and conditions associated with the disruption of cellular metabolism, in the treatment of obesity, including pathological forms thereof, and also for the treatment of diseases associated with the increased formation of free radicals and reactive oxygen species.
    Type: Application
    Filed: June 24, 2010
    Publication date: August 8, 2013
    Applicant: LIMITED LIABILITY COMPANY MITOTECH
    Inventors: Vladimir Petrovich Skulachev, Maxim Vladimirovich Skulachev, Roman Alexeevich Zinovkin, Fedor Fedorovich Severin, Yury Nikolaevich Antonenko, Dmitry Borisovich Zorov, Egor Yurievich Plotnikov, Nikolay Konstantinovich Isaev, Denis Nikolaevich Silachev, Dmitry Alexeevich Knorre
  • Publication number: 20110053895
    Abstract: The invention relates to pharmacology and medicine, in particular to a class of mitochondrially-addressed compounds which can be used in the pharmaceutical compositions of medicinal agents (preparations) for preventing and treating cardiovascular diseases and diseases and pathological conditions caused by disturbed blood circulation or oxygen supply to tissues and organs.
    Type: Application
    Filed: June 29, 2007
    Publication date: March 3, 2011
    Inventors: Maxim Vladimirovich Skulachev, Vladimir Petrovich Skulachev